D.Western Therapeutics Institute Inc banner
D

D.Western Therapeutics Institute Inc
TSE:4576

Watchlist Manager
D.Western Therapeutics Institute Inc
TSE:4576
Watchlist
Price: 95 JPY Market Closed
Market Cap: ¥5.2B

Multiples-Based Value

The Multiples-Based Value of one D.Western Therapeutics Institute Inc stock under the Base Case scenario is hidden JPY. Compared to the current market price of 95 JPY, D.Western Therapeutics Institute Inc is hidden .

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

D.Western Therapeutics Institute Inc Multiples-Based Value
LOCKED
Unlock
Worst Case
Base Case
Best Case

Multiples Across Competitors

Competitors Multiples
D.Western Therapeutics Institute Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
D.Western Therapeutics Institute Inc
TSE:4576
5.2B JPY 13.3 -8.2 -6.9 -6.4
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 690 872.8 -160 127.7 -194 446.1 -192 227.3
US
Abbvie Inc
NYSE:ABBV
373.2B USD 6.1 89.2 14.8 20.5
US
Exact Sciences Corp
NASDAQ:EXAS
356.4B USD 6.2 -96.2 951.3 -107.4
US
Amgen Inc
NASDAQ:AMGN
190.4B USD 5.2 24.7 14.3 14.3
US
Gilead Sciences Inc
NASDAQ:GILD
169.9B USD 5.8 20 12.5 15.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.2B USD 9.6 29.2 21.9 22.9
US
Epizyme Inc
F:EPE
94.1B EUR 2 091 -533.6 -581 -565.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80B USD 5.6 17.8 13.2 15.1
AU
CSL Ltd
ASX:CSL
69.6B AUD 3.2 34.9 11.5 14.4
US
Seagen Inc
F:SGT
39.3B EUR 20.1 -61.8 -66.6 -60.1
P/E Multiple
Earnings Growth PEG
JP
D
D.Western Therapeutics Institute Inc
TSE:4576
Average P/E: 35.9
Negative Multiple: -8.2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 127.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
89.2
97%
0.9
US
Exact Sciences Corp
NASDAQ:EXAS
Negative Multiple: -96.2 N/A N/A
US
Amgen Inc
NASDAQ:AMGN
24.7
20%
1.2
US
Gilead Sciences Inc
NASDAQ:GILD
20
16%
1.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
29.2
17%
1.7
US
E
Epizyme Inc
F:EPE
Negative Multiple: -533.6 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
13%
1.4
AU
CSL Ltd
ASX:CSL
34.9
10%
3.5
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.8 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
JP
D
D.Western Therapeutics Institute Inc
TSE:4576
Average EV/EBITDA: 148.5
Negative Multiple: -6.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 446.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
14.8
12%
1.2
US
Exact Sciences Corp
NASDAQ:EXAS
951.3
261%
3.6
US
Amgen Inc
NASDAQ:AMGN
14.3
10%
1.4
US
Gilead Sciences Inc
NASDAQ:GILD
12.5
9%
1.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
21.9
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -581 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.2
18%
0.7
AU
CSL Ltd
ASX:CSL
11.5
7%
1.6
US
S
Seagen Inc
F:SGT
Negative Multiple: -66.6 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
JP
D
D.Western Therapeutics Institute Inc
TSE:4576
Average EV/EBIT: 17.1
Negative Multiple: -6.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 227.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
20.5
23%
0.9
US
Exact Sciences Corp
NASDAQ:EXAS
Negative Multiple: -107.4 N/A N/A
US
Amgen Inc
NASDAQ:AMGN
14.3
3%
4.8
US
Gilead Sciences Inc
NASDAQ:GILD
15.4
13%
1.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.9
17%
1.3
US
E
Epizyme Inc
F:EPE
Negative Multiple: -565.5 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.1
23%
0.7
AU
CSL Ltd
ASX:CSL
14.4
10%
1.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.1 N/A N/A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett